Thaylon Davis
Myriad Genetics · 40 works · 5,755 citations · h-index 13
Top works
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
- MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
- The Protein Network of HIV Budding
- Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
- Low incidence of BRCA2 mutations in breast carcinoma and other cancers
- The Role of MMAC1 Mutations in Early-Onset Breast Cancer: Causative in Association with Cowden Syndrome and Excluded in BRCA1-Negative Cases
- Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes
- Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer
- Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1
- 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97)
- Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound
- Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma
- Cellular and In Vivo Properties of MPI‐0485520, a Novel and Potent Small Molecule Inhibitor of IKKe
- Phase I study of mFOLFOX-6, bevacizumab, and mTOR inhibitor RAD001 as first-line treatment of metastatic colorectal cancer.
- Hereditary cancer risk assessment and genetic testing in the community urology practice setting
- Validation of a cell cycle progression score for 5-year mortality risk in patients with stage I non-small cell lung cancer.
- Hereditary cancer risk assessment in the community urology practice setting.
- Supplemental Figure 2 from Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes
- Data from Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes